Researchers are exploring strategies to alter the gut microbiome to improve patients’ responses to immunotherapy. New ...

Faecal transplants can boost the immune systems of patients with advanced cancer, improving their response to immunotherapy.

host-microbiota interactions, and mechanisms of immune regulation. A strength of the program is the ability to translate laboratory findings into effective clinical applications. Scientists from our ...

The results have just been published in Nature Biomedical Engineering. The interaction between microbiota and immunotherapy has long been known. It is the result of both systemic effects ...

Two cancer patients were successfully treated with fecal microbiota transplants (FMTs) for colitis caused by immunotherapy, according to a case report published today (November 12) in Nature Medicine.

Gut microbiota may be the key factor explaining ... early supplementation with recombinant IgA antibodies, as a form of immunotherapy, to counteract the excessive immune response to gut bacteria ...

Analysis: Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses. Image Credit: Lightspring / Shutterstock In a recent study published in the journal ...

Most analyses of commensal microbiota have been directed toward the gut microbiota and its role in the development of the intestinal immune system, and in regulating the immune response at sites ...

The Gut-on-Chip makes it possible to test the gut microbiota of a patient with cancer, in this case melanoma, while waiting to undergo immunotherapy and to predict the outcome of that therapy.

MaaT Pharma’s quest to bring a microbiota-based therapy to market ... The French drugmaker is also testing MaaT013 as an immunotherapy for metastatic melanoma alongside checkpoint inhibitors ...